Levels of soluble Fas ligand in myocarditis

被引：54
|
作者：
Toyozaki, T
Hiroe, M
Tanaka, M
Nagata, S
Ohwada, H
Marumo, F
机构：
[1] Tokyo Med & Dent Univ, Dept Med 2, Div Cardiol, Bunkyo Ku, Tokyo 113, Japan
[2] Osaka Univ, Sch Med, Dept Genet, Osaka, Japan
[3] Chiba Univ, Sch Med, Inst Pulm Canc Res, Div Pathol, Chiba 280, Japan
来源：
AMERICAN JOURNAL OF CARDIOLOGY | 1998年 / 82卷 / 02期
关键词：
D O I：
10.1016/S0002-9149(98)00300-2
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Serum levels of soluble Fas Ligand (sFasL) increased with the severity of congestive heart failure (p <0.01), and the percentages of apoptotic myocytes detected by in situ DNA nick-end labeling were significantly higher in the patients with increased levels of sFasL than in those with normal levels of sFasL (p <0.05). These findings indicated that sFasL may play an important role in pathogenesis of myocarditis.
引用
收藏
页码：246 / +
页数：5
相关论文
共 50 条
  • [41] The Fas/Fas ligand system is involved in the pathogenesis of autoimmune myocarditis in rats
    Ishiyama, S
    Hiroe, M
    Nishikawa, T
    Shimojo, T
    Abe, S
    Fujisaki, H
    Ito, H
    Yamakawa, K
    Kobayashi, N
    Kasajima, T
    Marumo, F
    JOURNAL OF IMMUNOLOGY, 1998, 161 (09): : 4695 - 4701
  • [42] Increased levels of soluble Fas receptor and Fas ligand in the cerebrospinal fluid of HIV-infected patients
    Sporer, B
    Koedel, U
    Goebel, FD
    Pfister, HW
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2000, 16 (03) : 221 - 226
  • [43] Normal serum levels of soluble forms of Fas and Fas ligand in patients with cutaneous T cell lymphoma
    Dereure, O
    Llanos, F
    Portales, P
    Clot, J
    Guilhou, JJ
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2000, 115 (03) : 570 - 570
  • [44] Examination of soluble Fas (sFas) and soluble Fas ligand (sFasL) in patients with burns
    Yamada, Y
    Endo, S
    Nakae, H
    Makabe, H
    Sato, N
    Wakabayashi, G
    Kitamura, M
    Inada, K
    Sato, S
    BURNS, 2003, 29 (08) : 799 - 802
  • [45] Serum concentrations of soluble Fas antigen and soluble Fas ligand in mother and newborn
    H. Iwama
    H. Akutsu
    S. Kuretake
    J. Tohma
    N. Nakamura
    Archives of Gynecology and Obstetrics, 2000, 263 : 108 - 110
  • [46] Serum concentrations of soluble Fas antigen and soluble Fas ligand in mother and newborn
    Iwama, H
    Akutsu, H
    Kuretake, S
    Tohma, J
    Nakamura, N
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2000, 263 (03) : 108 - 110
  • [47] Soluble Fas receptor and soluble Fas ligand in the serum of women with uterine tumors
    Z. Kondera-Anasz
    A. Mielczarek-Palacz
    J. Sikora
    Apoptosis, 2005, 10 : 1143 - 1149
  • [48] Soluble Fas receptor and soluble Fas ligand in the serum of women with uterine tumors
    Kondera-Anasz, Z
    Mielczarek-Palacz, A
    Sikora, J
    APOPTOSIS, 2005, 10 (05) : 1143 - 1149
  • [49] Elevation of soluble Fas and soluble Fas ligand in reactive macrophage activation syndromes
    Emmenegger, U
    Zehnder, R
    Frey, U
    Reimers, A
    Spaeth, P
    Neftel, KA
    AMERICAN JOURNAL OF HEMATOLOGY, 2000, 64 (02) : 116 - 119
  • [50] Soluble FAS (S FAS) and soluble FAS ligand (S FAS-L) in human milk.
    Srivastava, MD
    FASEB JOURNAL, 1998, 12 (05): : A797 - A797
12345